title: PARP inhibitor and chemotherapy combination trials for the treatment of advanced malignancies: does a development pathway forward exist?
authors.affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
authors.forename: U A
authors.initials: UA
authors.lastname: Matulonis
authors.affiliation: Arizona Oncology (US Oncology Network), University of Arizona and Creighton University Phoenix, Phoenix, AZ, USA.
authors.forename: B J
authors.initials: BJ
authors.lastname: Monk
mesh_terms: D006801:Humans; D009369:Neoplasms; D010793:Phthalazines; D000067856:Poly(ADP-ribose) Polymerase Inhibitors
chemical_list: D010793:Phthalazines; D000067856:Poly(ADP-ribose) Polymerase Inhibitors